Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI108010

The Use of a Helium-Oxygen Mixture during Maximum Expiratory Flow to Demonstrate Obstruction in Small Airways in Smokers

James Dosman, Frederick Bode, John Urbanetti, Richard Martin, and Peter T. Macklem

1Collaborative Study of Smoking and Airways Obstruction, Meakins-Christie Laboratories, McGill University Clinic, Royal Victoria Hospital, Montreal, Canada, H3C 3G1

Find articles by Dosman, J. in: PubMed | Google Scholar

1Collaborative Study of Smoking and Airways Obstruction, Meakins-Christie Laboratories, McGill University Clinic, Royal Victoria Hospital, Montreal, Canada, H3C 3G1

Find articles by Bode, F. in: PubMed | Google Scholar

1Collaborative Study of Smoking and Airways Obstruction, Meakins-Christie Laboratories, McGill University Clinic, Royal Victoria Hospital, Montreal, Canada, H3C 3G1

Find articles by Urbanetti, J. in: PubMed | Google Scholar

1Collaborative Study of Smoking and Airways Obstruction, Meakins-Christie Laboratories, McGill University Clinic, Royal Victoria Hospital, Montreal, Canada, H3C 3G1

Find articles by Martin, R. in: PubMed | Google Scholar

1Collaborative Study of Smoking and Airways Obstruction, Meakins-Christie Laboratories, McGill University Clinic, Royal Victoria Hospital, Montreal, Canada, H3C 3G1

Find articles by Macklem, P. in: PubMed | Google Scholar

Published May 1, 1975 - More info

Published in Volume 55, Issue 5 on May 1, 1975
J Clin Invest. 1975;55(5):1090–1099. https://doi.org/10.1172/JCI108010.
© 1975 The American Society for Clinical Investigation
Published May 1, 1975 - Version history
View PDF
Abstract

We measured the response to breathing a mixture of 80% helium and 20% oxygen (He) during a maximum expiratory flow-volume (MEFV) maneuver in 66 nonsmokers and 48 smokers, aged 17-67. All of the subjects studied had (forced expiratory volume in 1 s/forced vital capacity [FEV1.0/FVC]) × 100 of greater than 70%. While the flow rates of the smokers were within ±2 SD of those of the nonsmokers at 50% VC (V̇max50), both groups showed a reduction in flow with age (nonsmokers: r=-0.34, P<0.01; smokers r=-0.52, P<0.001). Nonsmokers showed no significant reduction with age in response to breathing He, while smokers showed a marked reduction with age (r=-0.63, P<0.001 at V̇max50). We also measured the lung volume at which maximum expiratory flow (V̇max) while the subject was breathing He became equal to V̇max while he was breathing air, and expressed it as a percent of the VC. This was the most sensitive method of separating smokers from nonsmokers. These results indicate that the use of He during an MEFV maneuver affords sufficient sensitivity to enable detection of functional abnormalities in smokers at a stage when V̇max while they are breathing air is normal.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1090
page 1090
icon of scanned page 1091
page 1091
icon of scanned page 1092
page 1092
icon of scanned page 1093
page 1093
icon of scanned page 1094
page 1094
icon of scanned page 1095
page 1095
icon of scanned page 1096
page 1096
icon of scanned page 1097
page 1097
icon of scanned page 1098
page 1098
icon of scanned page 1099
page 1099
Version history
  • Version 1 (May 1, 1975): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts